Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 4
2001 5
2002 2
2003 2
2004 1
2005 2
2006 2
2007 2
2008 7
2009 3
2010 6
2011 8
2012 11
2013 15
2014 14
2015 8
2016 7
2017 8
2018 11
2019 11
2020 9
2021 16
2022 7
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.
Wharton S, Blevins T, Connery L, Rosenstock J, Raha S, Liu R, Ma X, Mather KJ, Haupt A, Robins D, Pratt E, Kazda C, Konig M; GZGI Investigators. Wharton S, et al. Among authors: mather kj. N Engl J Med. 2023 Sep 7;389(10):877-888. doi: 10.1056/NEJMoa2302392. Epub 2023 Jun 23. N Engl J Med. 2023. PMID: 37351564 Clinical Trial.
Cardiovascular consequences of metabolic syndrome.
Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Tune JD, et al. Among authors: mather kj. Transl Res. 2017 May;183:57-70. doi: 10.1016/j.trsl.2017.01.001. Epub 2017 Jan 9. Transl Res. 2017. PMID: 28130064 Free PMC article. Review.
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.
Heise T, Mari A, DeVries JH, Urva S, Li J, Pratt EJ, Coskun T, Thomas MK, Mather KJ, Haupt A, Milicevic Z. Heise T, et al. Among authors: mather kj. Lancet Diabetes Endocrinol. 2022 Jun;10(6):418-429. doi: 10.1016/S2213-8587(22)00085-7. Epub 2022 Apr 22. Lancet Diabetes Endocrinol. 2022. PMID: 35468322 Clinical Trial.
Response.
Thosar SS, Wallace JP, Mather KJ. Thosar SS, et al. Among authors: mather kj. Med Sci Sports Exerc. 2015 Sep;47(9):2001. doi: 10.1249/MSS.0000000000000710. Med Sci Sports Exerc. 2015. PMID: 26274550 No abstract available.
Cardiovascular and hemodynamic effects of glucagon-like peptide-1.
Goodwill AG, Mather KJ, Conteh AM, Sassoon DJ, Noblet JN, Tune JD. Goodwill AG, et al. Among authors: mather kj. Rev Endocr Metab Disord. 2014 Sep;15(3):209-17. doi: 10.1007/s11154-014-9290-z. Rev Endocr Metab Disord. 2014. PMID: 24881624 Free PMC article. Review.
Imaging of myocardial fatty acid oxidation.
Mather KJ, DeGrado TR. Mather KJ, et al. Biochim Biophys Acta. 2016 Oct;1861(10):1535-43. doi: 10.1016/j.bbalip.2016.02.019. Epub 2016 Feb 27. Biochim Biophys Acta. 2016. PMID: 26923433 Free PMC article. Review.
Does diabetes prevention translate into reduced long-term vascular complications of diabetes?
Nathan DM, Bennett PH, Crandall JP, Edelstein SL, Goldberg RB, Kahn SE, Knowler WC, Mather KJ, Mudaliar S, Orchard TJ, Temprosa M, White NH; Research Group. Nathan DM, et al. Among authors: mather kj. Diabetologia. 2019 Aug;62(8):1319-1328. doi: 10.1007/s00125-019-4928-8. Epub 2019 Jul 4. Diabetologia. 2019. PMID: 31270584 Free PMC article. Review.
153 results